Good morning :)
$
₹
Teleflex Incorporated

Teleflex Incorporated

TFX

NYSE
Asset Logo

Teleflex Incorporated

TFX

NYSE
$136.950.48% (+0.66)
$
₹
$136.950.48% (+0.66)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Mid Cap

With a market cap of $5.8B the stock is ranked 1368

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.82
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-8.48
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.16
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-45.76%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

1%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 12 analysts reports

Buy
6 analysts
Hold
6 analysts
Sell
0 analyst

Price Upside

+12.99%

Earnings Growth

-42.17%

Rev. Growth

+13.81%

See Detailed Forecast

Company Profile

Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
38.55
38.55
1Y Return
18.86%
18.86%
Buy Reco %
85.71
85.71
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.16
38.16
1Y Return
3.48%
3.48%
Buy Reco %
83.33
83.33
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
54.69
54.69
1Y Return
17.95%
17.95%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
23.44
23.44
1Y Return
1.27%
1.27%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
31.82
31.82
1Y Return
19.81%
19.81%
Buy Reco %
79.31
79.31
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 12.99% growth, versus a trailing 3-year CAGR of -9.54%.

2026
Current$136.29Baseline
Analyst Target - 1 year
Target$154+12.99%

All values in $

202220232024202520262027$149.76$189.68$229.60Target+12.99%
2026
Current$136.29Baseline
Analyst Target - 1 year
Target$154+12.99%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 13.81% growth, versus a trailing 3-year CAGR of -10.62%.

2025
Current$1.99Baseline
Forecast for Dec 2026
High$2.27+14.08%
Average$2.26+13.81%
Low$2.26+13.61%

All values in $ Billion

2021202220232024202520262.802.792.973.041.99Low+13.61%Average+13.81%High+14.08%
2025
Current$1.99Baseline
Forecast for Dec 2026
High$2.27+14.08%
Average$2.26+13.81%
Low$2.26+13.61%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -42.17% growth, versus a trailing 3-year CAGR of -2.14%.

2025
Current$12.24Baseline
Forecast for Dec 2026
High$7.26-40.7%
Average$7.08-42.17%
Low$7.01-42.73%

All values in $

20212022202320242025202613.3313.0613.5214.0112.24Low-42.73%Average-42.17%High-40.7%
2025
Current$12.24Baseline
Forecast for Dec 2026
High$7.26-40.7%
Average$7.08-42.17%
Low$7.01-42.73%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

913
-408.8
568.9
-714.3
548.2
-8.1
570.3
102
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue737.84749.69764.37795.40700.66780.88913.02568.98548.26570.33
Net Income15.2880.03111-136.6595122.58-408.89-714.32-8.15102.01
Net Profit Margin2.07%10.67%14.52%-17.18%13.55%15.69%-44.78%-125.54%-1.48%17.88%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Teleflex Incorporated -1.820.16
Abbott Laboratories38.553.572.12
Danaher Corporation38.162.951.32
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare TFX with any stock or ETF
Compare TFX with any stock or ETF
Comparing from
TFX
ABT
DHR
Loading...

Frequently asked questions

  1. Teleflex Incorporated (TFX) share price today is $136.95 as of October 27, 2026 at 1:29 AM IST. The stock touched a day high of $137.60 and a day low of $135.43.

  2. Teleflex Incorporated stock trades on NYSE under the ticker symbol TFX.

  3. Teleflex Incorporated's market capitalization is $5.77B as of October 27, 2026 at 1:29 AM IST.

  4. Teleflex Incorporated's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

  5. Teleflex Incorporated's price-to-book (P/B) ratio is 1.82 as of October 26, 2026.

  6. Yes, Teleflex Incorporated pays a dividend, with a current dividend yield of 1%.

  7. Yes, You can buy Teleflex Incorporated shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Teleflex Incorporated shares in three steps: 1. Search Teleflex Incorporated on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Teleflex Incorporated trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Teleflex Incorporated (TFX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.073 shares at the current price of $136.95.

Loading...